An Open-label, Non-randomized, Phase I Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Roniciclib in Patients With Advanced Solid Tumors
Phase of Trial: Phase I
Latest Information Update: 30 May 2016
At a glance
- Drugs Roniciclib (Primary) ; Itraconazole
- Indications Solid tumours
- Focus Pharmacokinetics
- Sponsors Bayer
- 20 May 2016 Status changed from active, no longer recruiting to completed.
- 18 Apr 2016 Planned End Date changed from 1 Oct 2016 to 1 May 2016.
- 18 Apr 2016 Status changed from recruiting to active, no longer recruiting.